Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reached a new 52-week high of $560.25 during today's trading session.
At publication ·
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) · 52 week high
At a glance
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reached a new 52-week high of $560.25 during today's trading session.
The Healthcare stock has traded year-to-date and 3.6% over the past week. The previous 52-week high was $560.25.
Vertex Pharmaceuticals Incorporated has a market capitalization of $114.5B. The stock's 52-week low was $412.27.
Reaching a 52-week high often signals strong momentum and investor confidence in Vertex Pharmaceuticals Incorporated. Stocks at new highs can continue trending higher as breakout buying kicks in, though they also face increased selling pressure from profit-taking. The key question is whether fundamentals support the elevated valuation.
Vertex Pharmaceuticals Incorporated currently trades at $559.41, positioning the stock at the 99th percentile of its 52-week range ($412.27 — $560.25). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View VRTX Stock Page
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our VRTX news page.
See full price history and interactive charts on our VRTX chart page.
Current market data
NASDAQ · VRTX
$540.00
Up: +$18.88 · +3.50%
Live quote updated
Keep reading
institutional ·
institutional ·
analyst ·
institutional ·
